Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer

British Journal of Cancer

Volumn 74, Issue 3, 1996, Pages 342-351

  Gotley, D C ^a,b   Fawcett, J ^c   Walsh, M D ^b   Reeder, J A ^a   Simmons, D L ^c   Antalis, T M ^a,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Alternative splicing; CD44; Colorectal cancer; Metastasis; Tumour progression

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADENOMATOUS POLYP; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER STAGING; CELLULAR DISTRIBUTION; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0030055727     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.364     Document Type: Article

References (34)

1. ANTALIS TM AND DICKINSON JL. (1992). Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur. J. Biochem., 205, 203 209.
2. ARUFFO A, STAMENKOVIC I, MELNICK M, UNDERHILL CB AND SEED B. (1989). CD44 is the principal cell surface receptor for hyaluronate. Cell, 61, 1303 1313.
3. BROWN TA, BOUCHARD T, ST JOHN T, WAYNER E AND CARTER WG. (1991). Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell. Biol., 113, 207 221.
4. CHOMCZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
5. DALL, P, HEIDER K-H, SINN H-P, SKROCH-ANGEL P, ADOLF G, KAUFMANN M, HERRLICH P AND PONTA H. (1995). Comparison of immunohistochemistry and RT - PCR for detection of CD44 variant-expression, a new prognostic factor in human breast cancer. Int. J. Cancer, 60, 471-477.
6. FEINBERG AP AND VOGELSTEIN B. (1983). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
7. FINKE LH, TERPE H-J, ZÖRB C, HAENSCH W AND SCHLAG PM. (1995). Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins (letter). Lancet, 345, 583.
8. FOX SB, FAWCETT J, JACKSON DG, COLLINS I, GATTER KC, HARRIS AL, GEARING A AND SIMMONS DL. (1994). Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546.
9. GÜNTHERT U, HOFMANN M, RUDY W, REBER S, ZÖLLER M, HAUBMANN I, MATZKU S, WENZEL A, PONTA H AND HERRLICH P. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13 24.
10. GUO Y, MA J, WANG J, CHE X, NARULA J, BIGBY M, WU M AND SY M-S. (1994). Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res., 54, 1561-1565.
11. HART IR, BIRCH M AND MARSHALL JF. (1991). Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metast. Rev., 10, 115-121.
12. HEIDER K-H, HOFMANN M, HORS E, VAN DEN BERG F, PONTA H, HERRLICH P AND PALS S. (1993). A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120, 227-233.
13. HEIDER K-H, DÄMMRICH J, SKROCH-ANGEL P, MÜLLER-HERMELINK H-K, VOLLMERS HP, HERRLICH P AND PONTA H. (1993). Differential expression of CD44 splice variants in intestinal and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53, 4197-4203.
14. HOFMANN M, RUDY W, ZÖLLER M, TÖLG C, PONTA H, HERRLICH P AND GÜNTHERT U. (1991). CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumour cell lines. Cancer Res., 51, 5292-5297.
15. HOFMANN M, RUDY W, GÜNTHERT U, ZIMMER SG, ZAWADZKI V, ZÖLLER M, LITCHNER RB, HERRLICH P AND PONTA H. (1993). A link between ras and metastatic behaviour of tumours cells: ras induces CD44 promoter activity and leads to low-level expression of metastastis-specific variants of CD44 in CREF cells. Cancer Res., 53, 1516 1521.
16. JACKSON DG, BUCKLEY J AND BELL JI. (1992). Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem., 267, 4732-4739.
17. JALKANEN S, JALKANEN M, BARGATZE R, TAMMI M AND BUTCHER EC. (1988). Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol., 141, 1615- 6123.
18. JALKANEN S, JOENSUU H, SÖDERSTRÖM KO AND KLEMI P. (1991). Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma. J. Clin. Invest., 87, 1835-1840.
19. JAMAL HH, CANO-GAUCI DF, BUICK RN AND FILMUS J. (1994). Activated ras and src induced CD44 overexpression in rat intestinal epithelial cells. Oncogene, 9, 417-423.
20. KIM H, YANG X-L, ROSADA C, HAMILTON SR AND AUGUST JT. (1994). CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys., 310, 504-507.
21. KOOPMAN G, HEIDER K-H, HORST E, ADOLF GR, VAN DEN BERG F, PONTA H, HERRLICH P AND PALS ST. (1993). Activated human lymphocytes and aggressive non-Hodgkins lymphomas express a homologue of the rat metastasis-associated variant CD44. J. Exp. Med., 177, 897 904.
22. MATSUMURA Y AND TARIN D. (1992). Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058.
23. MULDER JWR, WIELENGA VJM, POLAK MM, VAN DEN BERG FM, ADOLF GR, HERRLICH P, PALS ST AND OFFERHAUS GJA. (1995). Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut, 36, 76 80.
24. RUDY W, HOFMANN M, SCHWARTZ-ALBIEZ R, ZÖLLER M, HEIDER K-H, PONTA H AND HERRLICH P. (1993). The two-major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants: each one individually suffices to confer metastatic behaviour. Cancer Res., 53, 1262 1268.
25. SCREATON GR, BELL MV, JACKSON DG, CORNELIS FB, GERTH U AND BELL JI. (1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl Acad. Sci. USA, 89, 12160 12164.
26. SCREATON GR, BELL MV, BELL JI AND JACKSON DG. (1993). The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem., 268, 12235-12238.
27. SEITER S, ARCH R, REBER S, KOMITOWSKI D, HOFMANN M, PONTA H, HERRLICH P, MATZKU S AND ZÖLLER M. (1993). Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med., 177, 443 455.
28. SOUTHGATE J, TREJDOSIEWICZ LK, SMITH B AND SELBY PS. (1995). Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder carcinoma cell lines. Int. J. Cancer, 62, 449 456.
29. STAMENKOVIC I, AMIOT M, PESANDO JM AND SEED B. (1989). A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56, 1057-1062.
30. STAMENKOVIC I, ARUFFO A, AMIOT M AND SEED B. (1991). Human keratinocyptes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. EMBO J., 10, 343-348.
31. SY MS AND GUO YJ. (1991). Distinct effects of two CD44 isoforms on tumour growth in vivo. J. Med. Exp., 174, 859 866.
32. TAKADA M, YAMAMOTO M AND SAITOH Y. (1994). The significance of CD44 in human pancreatic cancer: I. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas, 9, 748 752.
33. TERPE H-J, STARK H, PREHM P AND GÜNTHERT U. (1994). CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry. 101, 79-89.
34. WIELENGA VJM, HEIDER K-H, OFFERHAUS GJA. ADOLF GR, VAN DEN BERG FM, PONTA H, HERRLICH P AND PALS ST. (1993). Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754 4756.